Company / Operating Income per Share
ORAMED PHARMACEUTICALS INC. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.32
FY2025
5-year range
-$1.03 / -$0.32
FY2021-FY2025
Trend
+18.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 10 years, ranging from $-1.03 in FY2023 to $-0.32 in FY2025.
Based on SEC 10-K filings.
-0.32 in FY2025.
Improved from $-1.03 to $-0.32 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 18.1% year-over-year.
- Lowest operating income per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.32 | +18.1% |
| FY2024 | -$0.39 | +61.9% |
| FY2023 | -$1.03 | -61.6% |
| FY2022 | -$0.63 | -27.8% |
| FY2021 | -$0.50 | +41.0% |
| FY2020 | -$0.84 | -35.7% |
| FY2019 | -$0.62 | +15.3% |
| FY2018 | -$0.73 | -30.8% |
| FY2017 | -$0.56 | -9.6% |
| FY2016 | -$0.51 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026